BioMarin Announces Record Fourth Quarter and Full Year 2022

BioMarin Announces Record Fourth Quarter and Full Year 2022 Total Revenues Driven by Strong Global Demand for VOXZOGO® and Steady Growth of Enzyme Business - read this article along with other careers information, tips and advice on BioSpace

Related Keywords

Germany , Australia , Japan , United States , Canada , Brazil , German , Marni Kottle , Traci Mccarty , Jean Jacques Bienaim , European Commission , Drug Administration , Biomarin Pharmaceutical Inc , Nasdaq , Replay International Number , International Number , Company Annual Report On Form , Exchange Commission , Development Expense , Inspection Of The Company , Prnewswire Biomarin Pharmaceutical Inc , Radiological Health , Development Portfolio , Biomarin Genzyme , Contribution Drives Record Full Year , Total Revenues , Net Income Expected Based , Full Year Guidance , Commercial Launch , Preparations Both Underway , Severe Hemophilia , Recently Submitted , Product Revenues Marketed , Net Product , Generally Accepted Accounting Principles , Marin Pharmaceutical , Marin Announces Record Furth Quarter , Full Year , Chief Executive Officer , Middle East , Product Approvals , Outcomes Based Agreements , Biologics License Application , Pre License Inspection , Premarket Approval , Product Life Cycle Expansion Opportunities , European Medicines , New York City , Hereditary Angioedema , Duchenne Muscular Dystrophy , Investigational New Drug , Year Financial Guidance , Canada Dial In Number , Dial In Number , International Dial In Number , Biomarin Pharmaceutical , Net Product Revenues , Administrative Expense , Quarterly Report , Nonqualified Deferred Compensation , Consolidated Financial Statements , Annual Report , Condensed Consolidated Statements , Twelve Months Ended December , Months Ended December , Asset Amortization , Contingent Consideration , Intangible Asset , From Income Taxes , Guidance Year Ending December , Resume , Careers , Iomarin Announces Record Fourth Quarter And Full Year 2022 Total Revenues Driven By Strong Global Demand For Voxzogo Steady Growth Of Enzyme Business , Iospace , Advice ,